Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Equity Ratio (2016 - 2025)

Editas Medicine (EDIT) has disclosed Equity Ratio for 11 consecutive years, with 0.07 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio fell 87.56% to 0.07 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.07, a 87.56% decrease, with the full-year FY2024 number at 0.39, down 43.79% from a year prior.
  • Equity Ratio was 0.07 for Q3 2025 at Editas Medicine, down from 0.09 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.82 in Q1 2022 to a low of 0.07 in Q3 2025.
  • A 5-year average of 0.62 and a median of 0.7 in 2022 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: surged 62.69% in 2021, then plummeted 87.56% in 2025.
  • Editas Medicine's Equity Ratio stood at 0.82 in 2021, then fell by 14.19% to 0.7 in 2022, then decreased by 0.27% to 0.7 in 2023, then tumbled by 43.79% to 0.39 in 2024, then crashed by 83.04% to 0.07 in 2025.
  • Per Business Quant, the three most recent readings for EDIT's Equity Ratio are 0.07 (Q3 2025), 0.09 (Q2 2025), and 0.24 (Q1 2025).